Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Prime Insulin Pen Prior to Administration

North Lima, Ohio Survey Completed on 07-24-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a registered nurse failed to properly administer insulin to a resident with type 2 diabetes mellitus and multiple other diagnoses, including hypertension and peripheral vascular disease. The resident had a physician's order for Humalog (Insulin Lispro) to be administered subcutaneously before meals according to a sliding scale based on finger-stick blood sugar (FSBS) results. During a medication administration observation, the nurse checked the resident's blood sugar, which was 238, and prepared to administer three units of insulin as ordered. However, the nurse did not prime the insulin pen prior to dialing the dose and administering the medication. Interview with the nurse confirmed that the insulin pen needle was not primed before use, and the nurse was uncertain about the specific priming instructions. Review of the manufacturer's instructions for the Insulin Lispro KwikPen indicated that the pen should be primed with two units before administration to ensure accurate dosing. The facility's policy required medications to be administered according to physician orders and manufacturer instructions, but this was not followed in this instance, resulting in the resident potentially receiving an incorrect dose of insulin.

An unhandled error has occurred. Reload 🗙